Quick Takeaways
- Provention Bio, Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2023.
- Headline metric: Return On Equity -98%.
- Info
- Insider Trading
- Financials
Provention Bio, Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2023.
- Location
- Red Bank, NJ
- Fiscal year end
- 31 December
- Latest financial report
- 29 Mar 2023
Shareable Research Card
Provention Bio, Inc. Financial Facts
Provention Bio, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.
Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.
- Context
- Latest metrics period: Q1 2023
- Latest reported value
- Return On Equity -98%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-5.4%</span>.
- Most recent SEC facts end date: 20 Mar 2023.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Source Evidence
Based on latest 10-Q/10-K
See Original Filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest SEC snapshot (2023-03-20) highlights Return On Equity -97.7%, Return On Assets -61.0%, and Operating Margin -993.9%.
Compare This Company Through SEC-backed Metrics
Use these links to compare Provention Bio, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.
NetIncomeLoss YoY
Latest value: 0.76%
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
42.1/100
Caution Confidence medium
Return On Equity
-98%
Metric score 0.0/100
Return On Assets
-61%
Metric score 0.0/100
Financial Health
- Current Ratio
- 1.93x
- Quick Ratio
- 0.5x
- Debt to Equity
- 0.5x
Strengths
Current Ratio and Debt-to-equity
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
-98%
YoY: -5.4%
Industry median: -43% (n=675)
Return On Assets
-61%
YoY: -30%
Industry median: -47% (n=673)
Operating Margin
-994%
YoY:
Industry median: -121% (n=298)
Current Ratio
1.93x
YoY: -56%
Industry median: 3.39x (n=667)
Quick Ratio
0.5x
YoY:
Industry median: 1.51x (n=289)
Debt-to-equity
0.5x
YoY: +180%
Industry median: 0.26x (n=530)
NetIncomeLoss YoY
0.76%
YoY:
Industry median: -0.93% (n=641)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | -98% | -5.4% |
| Return On Assets | -61% | -30% |
| Operating Margin | -994% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 1.93x | -56% |
| Quick Ratio | 0.5x | |
| Debt-to-equity | 0.5x | +180% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| NetIncomeLoss YoY | 0.76% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 94,780,874 | +48% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY